Artiva Biotherapeutics Inc Sustainability Reports
Artiva Biotherapeutics, Inc. is a clinical-stage biotechnology company focused on developing natural killer cell-based therapies. The company aims to develop effective and accessible treatments for patients with autoimmune diseases and cancers.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
FIGI: BBG00VPZJ0G8
1 reports from 2024 to 2024
Company Profile
Artiva Biotherapeutics, Inc. is a clinical-stage biotechnology company focused on developing natural killer cell-based therapies. The company aims to develop effective and accessible treatments for patients with autoimmune diseases and cancers.
Reports
1 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
Years
